Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors

NCT05645315 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TQB2618 injection and TQB2450 injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.